WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.
Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, von Euw EM, Yang PT, Chen HW, Haydu L, Toroni RA, Lucero OM, Chien AJ, Moon RT.
Anastas JN, et al. Among authors: chien aj.
J Clin Invest. 2014 Jul;124(7):2877-90. doi: 10.1172/JCI70156. Epub 2014 May 27.
J Clin Invest. 2014.
PMID: 24865425
Free PMC article.